Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Lettmaier

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2020
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfallsFlorian Putz, Veit Mengling, Rosalind Perrin, et al.
Cancers|December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer CenterLars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Cancers|September 28, 2023
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume DesignThomas Weissmann, Sina Mansoorian, Matthias Stefan May, et al.
Frontiers in Oncology|March 6, 2023
Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracyThomas Weissmann, Yixing Huang, Stefan Fischer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 6, 2024
The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planningFlorian Putz, Sogand Beirami, Manuel Alexander Schmidt, et al.
Journal of Clinical Medicine|October 23, 2021
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring ApproachThomas Weissmann, Stefan Speer, Florian Putz, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Journal of Neuro-Oncology|May 1, 2025
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volumeSina Mansoorian, Manuel Schmidt, Thomas Weissmann, et al.
Frontiers in Immunology|June 7, 2024
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survivalAnke Mittelstädt, Anna Anthuber, Paul David, et al.
Plos One|June 14, 2022
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatmentNina N Harke, Christian Wagner, Robert M Hermann, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 25, 2020
Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfallsFlorian Putz, Veit Mengling, Rosalind Perrin, et al.
Cancers|December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer CenterLars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Cancers|September 28, 2023
Deep Learning and Registration-Based Mapping for Analyzing the Distribution of Nodal Metastases in Head and Neck Cancer Cohorts: Informing Optimal Radiotherapy Target Volume DesignThomas Weissmann, Sina Mansoorian, Matthias Stefan May, et al.
Frontiers in Oncology|March 6, 2023
Deep learning for automatic head and neck lymph node level delineation provides expert-level accuracyThomas Weissmann, Yixing Huang, Stefan Fischer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 6, 2024
The Segment Anything foundation model achieves favorable brain tumor auto-segmentation accuracy in MRI to support radiotherapy treatment planningFlorian Putz, Sogand Beirami, Manuel Alexander Schmidt, et al.
Journal of Clinical Medicine|October 23, 2021
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring ApproachThomas Weissmann, Stefan Speer, Florian Putz, et al.
International Journal of Cancer|April 25, 2025
Limited association between HRR gene alterations and HRD in molecular tumor board cancer samples: Who should be tested for HRD?Christoph Schubart, Lars Tögel, Maria Giulia Carta, et al.
Journal of Neuro-Oncology|May 1, 2025
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volumeSina Mansoorian, Manuel Schmidt, Thomas Weissmann, et al.
Frontiers in Immunology|June 7, 2024
Exosomal ROR1 in peritoneal fluid identifies peritoneal disseminated PDAC and is associated with poor survivalAnke Mittelstädt, Anna Anthuber, Paul David, et al.
Plos One|June 14, 2022
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatmentNina N Harke, Christian Wagner, Robert M Hermann, et al.
Pageof 6